As COVID-19 spread to the USA, a study of 2736 hospitalized COVID-19 patients in New York found that 36% had elevated cardiac troponin I (cTnI) concentrations and that even a small elevation was associated with an increased risk of death [6]. Here, TNNI3 is linked to COVID-19.